CHAF1A knock-down experiments in the H1299 NSCLC cell line indicate that CHAF1A promotes proliferation and inhibits apoptosis in cancer cells [48,49], effects that are blocked by the overexpression of miR-520b, which directly targets CHAF1A [50]. This evidence concerns the gene CHAF1A and non-small cell lung carcinoma.